title: Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.
authors.affiliation: Department of Cardiology, University Hospital Magdeburg, Magdeburg, Germany. andreas.bollmann@medizin.uni-magdeburg.de
authors.forename: Andreas
authors.initials: A
authors.lastname: Bollmann
authors.forename: Karl-Heinz
authors.initials: KH
authors.lastname: Binias
authors.forename: Ines
authors.initials: I
authors.lastname: Toepffer
authors.forename: Jochen
authors.initials: J
authors.lastname: Molling
authors.forename: Christoph
authors.initials: C
authors.lastname: Geller
authors.forename: Helmut U
authors.initials: HU
authors.lastname: Klein
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000628:therapy*; D004341:Drug Evaluation; D004452:Echocardiography; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D005424:Flecainide / Q000008:administration & dosage* / Q000627:therapeutic use*; D006325:Heart Atria / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology*; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D005424:Flecainide